Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
KLF11 mutations have been described in small autosomal dominant pedigrees with early-onset non–ketosis-prone diabetes consistent with MODY7. A novel heterozygous variant c.31G>A (p.Asp11Asn) was identified in a three-generation family with four carriers—three with diabetes mellitus and one with impaired glucose tolerance (PMID:36874436). A second three-generation family harbored c.577C>A (p.Pro193Thr) co-segregating with diabetes in three affected relatives (PMID:36241199). Despite these reports, population-scale analyses and a recent review have questioned the penetrance and prevalence of KLF11 variants in MODY7 (PMID:36944622).
Functional studies demonstrate that KLF11 binds the insulin promoter and regulates transcription in pancreatic β-cells. Reporter assays and chromatin immunoprecipitation confirm direct KLF11‐insulin promoter interaction, and MODY7-associated variants significantly impair promoter activity and glucose-stimulated insulin secretion (PMID:15774581). Klf11 knockout mice exhibit altered insulin sensitivity but do not develop overt diabetes, supporting a dosage-sensitive role in β-cell function (PMID:26248217). Taken together, limited pedigrees and functional concordance support a possible role for KLF11 in MODY7, but incomplete penetrance and inconsistent population data warrant further study. Key take-home: KLF11 variants should be considered in MODY gene panels, with cautious interpretation given limited clinical prevalence data.
Gene–Disease AssociationLimitedSmall number of heterozygous pedigrees (n=2 families, 7 affected across 2 pedigrees), limited population evidence, and incomplete penetrance Genetic EvidenceLimitedVariants reported in two unrelated families with 7 heterozygous carriers, including c.31G>A (p.Asp11Asn) ([PMID:36874436]) and c.577C>A (p.Pro193Thr) ([PMID:36241199]) Functional EvidenceModerateIn vitro assays demonstrate KLF11 binds and regulates the insulin promoter and MODY7-associated variants impair transcriptional activity ([PMID:15774581]); Klf11-/- mice display altered insulin sensitivity ([PMID:26248217]) |